Male Breast Cancer
📧 Sign up to get email alerts when something new happens for Male Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-05-04Clinical Trial Update: Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating neoadjuvant tipifarnib with docetaxel and capecitabine in adults with locally advanced or metastatic bre…
-
CLINICAL_TRIALS research · 2015-03-24Clinical Trial Update: Sense of Hope Alleviates Fatigue in Breast Cancer Survivors
This clinical trial update covers a study evaluating a psychosocial intervention called "Sense of Hope" to alleviate fatigue in breast cance…
-
CLINICAL_TRIALS trial_result · 2015-03-23Clinical Trial Update: Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery [Phase 2]
A Phase 2 trial evaluating paclitaxel with or without carboplatin and/or bevacizumab, followed by doxorubicin and cyclophosphamide, in patie…
-
CLINICAL_TRIALS trial_result · 2015-03-05Clinical Trial Update: Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer [Phase 1, Phase 2]
Clinical trial update for metastatic breast cancer evaluating a vaccine therapy in combination with the IDO pathway inhibitor 1-MT; the phas…
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen [Phase 2]
A Phase 2 study evaluated the combination of lapatinib and tamoxifen in patients with locally advanced or metastatic breast cancer that prog…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-11-07Clinical Trial Update: Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy [NA]
A completed clinical trial investigating vorinostat in male and recurrent stage IV breast cancer patients undergoing aromatase inhibitor the…
-
CLINICAL_TRIALS trial_result · 2014-11-06Clinical Trial Update: Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy [NA]
Clinical trial update on vorinostat for stage IV breast cancer in patients receiving hormone therapy; study completed with results posted in…
-
CLINICAL_TRIALS trial_result · 2014-10-23Clinical Trial Update: Akt Inhibitor MK2206 in Combination With Lapatinib Ditosylate in Patients With Advanced or Metastatic Solid Tumors or Breast Cancer [Phase 1]
A Phase 1 trial evaluated MK-2206 in combination with lapatinib in patients with advanced or metastatic breast cancer, including HER2-positi…
-
CLINICAL_TRIALS trial_result · 2014-01-20Clinical Trial Update: Saracatinib in Treating Patients With Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed By Surgery [Phase 2]
This is a Phase 2 trial update of saracatinib for metastatic or unresectable locally advanced breast cancer. It includes estrogen receptor-n…
-
CLINICAL_TRIALS research · 2013-12-11Clinical Trial Update: Vaccine Therapy in Treating Patients With Metastatic Breast Cancer [Phase 1]
A Phase 1 vaccine therapy trial for metastatic breast cancer sponsored by the National Cancer Institute has been terminated. The study inclu…
-
CLINICAL_TRIALS trial_result · 2013-06-06Clinical Trial Update: Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases [Phase 2]
A Phase 2 study sponsored by the NCI evaluated lapatinib for brain metastases in patients with stage IV HER2-positive breast cancer; the tri…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors [Phase 1]
Phase 1 trial evaluating the safety and preliminary activity of combining interleukin-12, paclitaxel, and trastuzumab in patients with vario…
-
CLINICAL_TRIALS withdrawal · 2013-05-17Clinical Trial Update: Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast Cancer [Phase 1]
This clinical trial update notes the withdrawal of a Phase 1 study of ex vivo-expanded HER2-specific T cells with cyclophosphamide following…
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Trastuzumab and Flavopiridol in Treating Patients With Metastatic Breast Cancer [Phase 1]
Phase 1 trial of trastuzumab with flavopiridol in metastatic breast cancer, including HER2-positive and male breast cancer, has been termina…
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating a rebeccamycin analogue for Stage IIIB or Stage IV breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast Cancer [Phase 2]
A Phase 2 trial evaluated the combination of trastuzumab and gefitinib in metastatic breast cancer, and the study status is completed.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: 3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating triapine (3-AP) with gemcitabine for refractory metastatic breast cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2011-04-28Clinical Trial Update: Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer [Phase 2]
Phase 2 trial update evaluating bevacizumab in combination chemotherapy for lymph node-positive breast cancer. The study included male breas…